Form 8-K Kiniksa Pharmaceuticals, For: Apr 23
false
0001730430
0001730430
2024-04-23
2024-04-23
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of... (continue reading...)
Form 8-K FLORIDA POWER & LIGHT For: Apr 23 Filed by: NEXTERA ENERGY INC
0000753308false0000037634FLfalse00007533082024-04-232024-04-230000753308nee:FloridaPowerLightCompanyMember2024-04-232024-04-230000753308us-gaap:CommonStockMember2024-04-232024-04-230000753308nee:CorporateUnits6926Member2024-04-232024-04-23UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-K CURRENT REPORTPURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934Date of earliest event reported: April 23, 2024 CommissionFileNumber... (continue reading...)
Form 8-K Fusion Pharmaceuticals For: Apr 22
00-0000000 false 0001805890 0001805890 2024-04-22 2024-04-22
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 22, 2024
Fusion Pharmaceuticals Inc.
(Exact name of Registrant as Specified in Its Charter)
Canada 001-39344 ... (continue reading...)
Form 8-K PULTEGROUP INC/MI/ For: Apr 23
0000822416falsetrue00008224162024-04-232024-04-230000822416us-gaap:CommonStockMember2024-04-232024-04-230000822416phm:SeriesAJuniorParticipatingPreferredSharePurchaseRightsMember2024-04-232024-04-23UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, DC 20549FORM 8-K CURRENT REPORTPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934Date of Report (Date of earliest event reported): April 23, 2024 PULTEGROUP, INC. (Exact name of registrant as... (continue reading...)
Form 8-K NEXTERA ENERGY PARTNERS, For: Apr 23
false000160314500016031452024-04-232024-04-23UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-K CURRENT REPORTPURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934Date of earliest event reported: April 23, 2024 CommissionFileNumberExact name of registrant as specified in itscharter, address of principal executive offices andregistrant's telephone numberIRS EmployerIdentificationNumber1-36518NEXTERA ENERGY PARTNERS, LP... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K General Motors Financial For: Apr 23
-
Form D Corner Therapeutics,
-
Form 8-K LOCKHEED MARTIN CORP For: Apr 23
-
Form 8-K LINCOLN ELECTRIC HOLDING For: Apr 19
-
Form 8-K Atlantic Union Bankshare For: Apr 23
-
Form 8-A12B/A United Airlines Holdings
-
Form 8-K LKQ CORP For: Apr 23
-
Form 6-K Sendas Distributor S.A. For: Jun 30
-
Form D SPYNE AN ANVAYA SPV A
-
Form 4 Earth Science Tech, Inc. For: Apr 22 Filed by: Saumat Giorgio R.
-
Form 8-K Cornerstone Building For: Apr 22
-
Form ARS Desktop Metal, Inc. For: Dec 31
-
Form 8-K General Motors Co For: Apr 23
-
Form DEFA14A Desktop Metal, Inc.
-
Form DEF 14A Desktop Metal, Inc. For: Jun 07
-
Form 8-K Dime Community Bancshare For: Apr 23
-
Form 8-K FISERV INC For: Apr 23
-
Form ARS Syros Pharmaceuticals, For: Dec 31
-
Form ARS Cabaletta Bio, Inc. For: Dec 31
-
Form 6-K ONECONNECT FINANCIAL For: Apr 23
-
Form 8-K HALLIBURTON CO For: Apr 23
-
Form D VIVIFI MEDICAL SPV 2023
-
Form 6-K ONECONNECT FINANCIAL For: Apr 23
-
Form 8-K SHERWIN WILLIAMS CO For: Apr 23
-
Form 6-K ProQR Therapeutics N.V. For: Apr 23
-
Form DEFA14A Syros Pharmaceuticals,
-
Form DEFA14A Cabaletta Bio, Inc.
-
Form 8-K KIMBERLY CLARK CORP For: Apr 23
-
Form 8-K Philip Morris Internatio For: Apr 23
-
Form 6-K Mobilicom Ltd For: Apr 23
-
Form DEF 14A Syros Pharmaceuticals, For: Jun 05
-
Form DSTRBRPT International Finance
-
Form 8-K CAMBRIDGE BANCORP For: Apr 23
-
Form DSTRBRPT International Finance
-
Form DEF 14A Cabaletta Bio, Inc. For: Jun 03
-
Form DSTRBRPT International Finance
-
Form 8-K Seres Therapeutics, Inc. For: Apr 19
-
Form 10-Q MANHATTAN BRIDGE CAPITAL For: Mar 31
-
Form 8-K ClearSign Technologies For: Apr 22
-
Form 8-K Theriva Biologics, Inc. For: Apr 23
-
Form 10-Q MBC FUNDING II CORP. For: Mar 31
-
Form 6-K Tiziana Life Sciences For: Apr 23
-
Form 8-K CAMBRIDGE BANCORP For: Apr 23
-
Form 8-K Option Care Health, Inc. For: Apr 23
-
Form 8-K RTX Corp For: Apr 23
-
Form 10-Q BANK OF HAWAII CORP For: Mar 31
-
Form 8-K PENTAIR plc For: Apr 23
-
Form 8-K RYDER SYSTEM INC For: Apr 23
-
Form 8-K MSCI Inc. For: Apr 23
-
Form 1-K Red Oak Capital Fund For: Dec 31